Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 1,372 other Healthcare companies
Ranked #552 of 1,373 · scores higher than 60% of peers · safety percentile 60
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including MMED · Click a bar to see the companies
A mix: stronger debt / equity, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.02× | 0.24× | 86% | 33% | |
| BetaLower is better · 1,320 reported | Not reported | 0.53 | — | — | 33% |
| Current ratioHigher is better · 1,338 reported | 1.81× | 2.62× | 36% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 548 | 30M USD | 60 | ||
| 549 | 6.4B CNY (≈$894M) | 60 | 60 | |
| 550 | 1.8B USD | 60 | 80 | |
| 551 | 2.1B CNY (≈$290M) | 60 | 27 | |
| 552 | 5.3B USD | 60 | 50 | |
| 553 | 7.2B CNY (≈$1.0B) | 60 | 74 | |
| 554 | 34.2B CNY (≈$4.8B) | 60 | 59 | |
| 555 | 3.1B CNY (≈$439M) | 60 | 25 | |
| 556 | 11.9B USD | 60 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score